BioSpace News Archive

Drug Development

Atom Bioscience to Present Final Data from its Positive Phase 2a Clinical Trial in Chronic Gout at American College of Rheumatology Annual Meeting, Nov. 10 – 14, in Philadelphia, PA

Atom Bioscience announced that it will present final dated data from its Phase 2a clinical trial of its small molecule URAT1 inhibitor for treatment of chronic gout at the American College of Rheumatology annual meeting, Convergence 22, in Philadelphia, PA, Nov. 10-14.

November 10, 2022
·
4 min read
Business

Daré Bioscience Reports Third Quarter 2022 Financial Results and Provides a Company Update

Daré Bioscience, Inc., a leader in women’s health innovation, reported financial results for the quarter ended September 30, 2022 and provided a company update.

November 10, 2022
·
16 min read
Pharm Country

BD Board Increases Dividend for 51st Consecutive Year

The Board of Directors of BD has declared a quarterly dividend of $0.91 per common share, an increase of 4.6% from the previous quarter. The dividend will be payable on Dec. 30, 2022 to holders of record on Dec. 9, 2022.

November 10, 2022
·
2 min read
Genetown

CENTOGENE to Participate in Upcoming Conferences in November 2022

Centogene N.V., the essential life science partner for data-driven answers in rare and neurodegenerative diseases, announced its conference schedule for November 2022.

November 10, 2022
·
4 min read
Business

BD Reports Fourth Quarter and Full Year Fiscal 2022 Financial Results

BD, a leading global medical technology company, announced results for its fourth quarter and full year of fiscal 2022, which ended September 30, 2022.

November 10, 2022
·
19 min read
Pharm Country

Immunic to Participate in Investor and Scientific Conferences in November and December 2022

Immunic, Inc. announced participation in the following investor and scientific conferences in November and December.

November 10, 2022
·
7 min read
Genetown

ROME Therapeutics Demonstrates Efficacy of its Novel LINE-1 Reverse Transcriptase Inhibitor in Translational Models of Autoimmune Disease

ROME Therapeutics today announced it will share preclinical data from its lead program, a LINE-1 reverse transcriptase inhibitor, in a poster presentation at American College of Rheumatology (ACR) Convergence 2022, taking place November 10 – 14, 2022, in Philadelphia.

November 10, 2022
·
2 min read
Business

NRx Pharmaceuticals to Report Third Quarter 2022 Results on November 14, 2022

NRx Pharmaceuticals, Inc. today announced that management will report third quarter 2022 financial results prior to the market open on November 14, 2022.

November 10, 2022
·
4 min read
Immunocore to present at the 2022 Jefferies London Healthcare Conference

Immunocore Holdings Plc announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference.

November 10, 2022
·
1 min read
Drug Development

Aura Announces Global Phase 3 Trial Design with Suprachoroidal Route of Administration Based on Positive Phase 2 Interim Data of Belzupacap Sarotalocan in Early-Stage Choroidal Melanoma

Aura Biosciences Inc. today announced that it has initiated startup activities for the global Phase 3 trial.

November 10, 2022
·
6 min read